UCLA Clinical Translational Research Center
Welcome,         Profile    Billing    Logout  
 6 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Belperio, John
ELEVAATE, NCT05856331: Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

Active, not recruiting
2
99
Europe, US, RoW
SAR447537, Zemaira, Respreeza
Sanofi
Alpha 1-Antitrypsin Deficiency, Emphysema
08/25
10/25
IPF-PRO, NCT01915511: Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Checkmark
Oct 2015 - Oct 2015: 
Recruiting
N/A
3000
US
Duke University, Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
01/28
01/28
Weigt, Stephen
MINT, NCT05799755: Myositis Interstitial Lung Disease Nintedanib Trial

Active, not recruiting
4
70
US
Nintedanib, OFEV, Placebo, Standard of Care
Rohit Aggarwal, MD, Boehringer Ingelheim
Myositis Associated Interstitial Lund Disease (MA-ILD)
07/25
12/25
TETON-PPF, NCT05943535: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis

Recruiting
3
698
Canada, US, RoW
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
11/27
11/27
Clark, Jesse L
NCT06233799: Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

Recruiting
3
360
US
extended-release naltrexone (XR-NTX), Vivitrol, extended release bupropion (BUP-XL) tablets (BUP-XL), Wellbutrin, iPLB, Placebo injections, oPLB, Placebo tablets
National Institute on Drug Abuse (NIDA)
Methamphetamine-dependence, Methamphetamine Abuse
10/26
04/27
MURB, NCT05283304: Monthly Injectable BUP for MA Use Disorder () Trial

Terminated
2
18
US
Buprenorphine injection (BUP-Inj), SublocadeTM, Indivior, Placebo injection, Placebo injection (PBO-Inj)
Madhukar H. Trivedi, MD
Methamphetamine-dependence
10/23
11/23
CURB-2, NCT05262270: Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder

Recruiting
2
426
US
Extended-Release Naltrexone, XR-NTX, Extended Release Buprenorphine, XR-BUP, Placebo (PLB) Injectable matched to XR-NTX, Injectable matching (to XR-NTX) placebo, Placebo (PLB) Injectable matched to XR-BUP, Injectable matching (to XR-BUP) placebo
University of Texas Southwestern Medical Center, National Institute on Drug Abuse (NIDA)
Cocaine Use Disorder
03/25
09/26
NCT05217641: A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

Active, not recruiting
1
108
US
BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA
National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services
HIV Infections
07/23
06/27
NCT04614584: Mirtazapine and Methamphetamine Drug-drug Interaction Study

Completed
1
15
US
Mirtazapine, Methamphetamine
San Francisco Department of Public Health, University of California, Los Angeles
Methamphetamine Use Disorder, Drug Interaction, Cardiovascular Abnormalities
05/24
05/24
EPT and MSM, NCT04553211: Expedited Partner Therapy and the HIV Prevention Cascade

Completed
N/A
555
RoW
EPT
University of California, Los Angeles, Asociacion Civil Via Libre, University of California, San Francisco, Emory University
HIV-1-infection, Gonorrhea Male, Chlamydia, Partner Communication
04/24
04/24
Yang, Otto
NCT03325855: Fecal Microbiota Transplant National Registry

Recruiting
N/A
4000
Canada, US
None - Observational, Observational
American Gastroenterological Association, OpenBiome, University of California, San Diego, Commure, University of Pennsylvania, University of Minnesota, Loyola University Chicago
Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome
08/27
08/27
Rivera, Adreanne
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

Completed
3
214
US
Open-label pitolisant, Double-blind placebo, Double-blind pitolisant
Harmony Biosciences, LLC
Idiopathic Hypersomnia
09/23
09/23
NCT06282770: Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery

Recruiting
N/A
80
US
Laser Diode Brace, Laser Brace, Sham Laser Diode Brace, Shame Brace
University of California, Los Angeles
Spinal Fusion, Chronic Lower Back Pain
07/24
07/25
NAPS2, NCT05826457: North American Prodromal Synucleinopathy Consortium Stage 2

Recruiting
N/A
500
Canada, US
Washington University School of Medicine, Mayo Clinic, University of Minnesota, University of California, Los Angeles, McGill University, Emory University, Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke (NINDS), Stanford University, National Institutes of Health (NIH), Oregon Health and Science University, National Institute on Aging (NIA)
REM Sleep Behavior Disorder, Parkinson Disease, Lewy Body Dementia, Dementia With Lewy Bodies, Multiple System Atrophy, REM Sleep Parasomnias
05/25
05/25
Shino, Yusaku Michael
NCT05280158: High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients

Completed
1/2
19
US
mRNA-1273 (Moderna COVID-19 vaccine)
University of California, Los Angeles, ModernaTX, Inc.
Lung Transplant Recipient, SARS-CoV-2, Immunosuppression
02/23
02/23
Elashoff, David
No trials found

Download Options